查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1710947

2025年全球植入式心臟装置市场报告

Implantable Cardiac Devices Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年植入式心臟装置的市场规模将强劲成长。到 2029 年，这一数字将成长至 188.1 亿美元，复合年增长率为 8.7%。预测期内的成长可归因于设备功能的技术进步、对微创手术的需求增加、老年人口的成长、医疗保健支出的增加以及新兴市场的医疗保健基础设施的扩大。预测期内的关键趋势包括数位健康和​​远端监控的整合、具有增强功能的下一代设备的开发、个人化和针对患者的心臟解决方案的增长、对成本效益和基于价值的医疗保健的重视、对预防心臟病学和早期疗育的日益关注。

心臟病患病率的不断上升预计将推动植入式心臟设备市场的成长。这种增长可能与多种风险因素有关，包括不健康的饮食、久坐的生活方式、肥胖以及糖尿病和高血压等慢性疾病。此外，人口老化和压力水平上升也导致心血管疾病发生率上升。植入式心臟装置对于控制和治疗心臟衰竭、心律不整和冠状动脉疾病等病症至关重要。对这些设备日益增长的需求正在推动创新和投资，以开发新的和改进的解决方案，以满足日益增长的患者群体的需求并改善治疗结果。例如，2024 年 5 月，新加坡心臟基金会 (SHF) 报告称，因缺血性心臟疾病死亡的人数为 5,302 人，略高于 2022 年的 5,290 人。因此，心臟病患病率的上升正在推动植入式心臟设备市场的成长。

植入式心臟设备市场的主要企业正致力于提高与 AutoMRI 等诊断工具的兼容性，以延长设备寿命并提高患者安全性。植入式心臟心臟去颤器中的 AutoMRI 功能可自动调整设备设置，以确保 MRI 扫描期间的安全操作，改善患者照护，同时更轻鬆地使用先进的成像技术。例如，2023年10月，法国医疗设备製造商MicroPort CRM在日本推出了其ULYS植入式心臟整流去颤器（ICD）和INVICTA去心房颤动。这些产品采用了先进的技术，具有低电流消耗，可延长设备寿命并具有 MRI 相容性。 ULYS ICD配备PARAD+心律不整辨识演算法和Aut​​MRI功能，INVICTA导线提供精确的起搏和去心房颤动治疗，临床试验中植入成功率达100%，无併发症率达97.4%。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场 - 宏观经济情景，包括利率、感染疾病、地缘政治、新冠疫情、经济復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球植入式心臟装置 PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球植入式心臟装置市场：成长率分析
  • 全球植入式心臟装置市场表现：规模与成长，2019-2024
  • 全球植入式心臟装置市场预测：规模与成长，2024-2029 年，2034 年
  • 植入式心臟设备的全球总目标市场（TAM）

第六章市场区隔

  • 全球植入式心臟设备市场类型、效能及预测（2019-2024 年、2024-2029 年及 2034 年）
  • 起搏器
  • 植入式心臟整流去颤器（ICD）
  • 双心室植入式心臟整流去颤器(BI-V ICD)
  • 全球植入式心臟装置市场：应用、效能及预测，2019-2024 年、2024-2029 年、2034 年
  • 心搏过缓
  • 心搏过速
  • 心臟衰竭
  • 其他用途
  • 全球植入式心臟设备市场（按最终用户、性能和预测）2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 专科诊所
  • 其他最终用户
  • 全球植入式心臟设备市场起搏器细分：单室调节器，按类型、实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 短链咪唑寡聚物
  • 长链咪唑啉寡聚物
  • 液体肥料溶液
  • 全球植入式心臟设备市场：植入式心臟整流去颤器(ICD) 细分市场（按类型、实际值及预测），2019-2024 年、2024-2029 年、2034 年
  • 静脉ICD
  • 皮下ICD
  • 心臟去颤器
  • 全球植入式心臟设备市场双心室植入式心臟整流去颤器(BI-V ICD) 细分市场（按类型、实际值及预测），2019-2024 年、2024-2029 年、2034 年
  • 标准 BI-V ICD
  • 先进的 BI-V ICD 及心臟再同步治疗 (CRT)

第七章 区域和国家分析

  • 全球植入式心臟装置市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球植入式心臟装置市场：依国家/地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 植入式心臟装置市场：竞争格局
  • 植入式心臟装置市场：公司简介
    • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • Koninklijke Philips NV Overview, Products and Services, Strategy and Financial Analysis
    • Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • Boston Scientific Corporation
  • B. Braun Melsungen AG
  • Edwards Lifesciences Corporation
  • Biotronik SE & Co. KG
  • Zoll Medical Corporation
  • Nihon Kohden Corporation
  • LivaNova plc
  • Lepu Medical Technology
  • MicroPort Scientific Corporation
  • AtriCure Inc.
  • LifeTech Scientific Corporation
  • Berlin Heart GmbH
  • EBR Systems Inc.
  • Defibtech LLC
  • CVRx Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029年植入式心臟设备市场：提供新机会的国家
  • 2029年植入式心臟设备市场：细分市场将带来新机会
  • 2029年植入式心臟设备市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r31972

Implantable cardiac devices are medical instruments that are surgically inserted into the body to assist in the management of heart disorders, especially those associated with irregular heart rhythms (arrhythmias) or heart failure. These devices monitor cardiac activity and often provide electrical impulses to regulate or correct abnormal heartbeats.

The primary categories of implantable cardiac devices consist of pacemakers, implantable cardioverter defibrillators (ICDs), and biventricular implantable cardioverter defibrillators (BI-V ICDs). A pacemaker is a compact medical device positioned beneath the skin in the chest area, designed to manage irregular heartbeats by delivering electrical impulses that prompt the heart to maintain a normal rhythm when its natural pacemaker is inadequate. This device is essential in treating conditions such as bradycardia and various arrhythmias. Applications for these devices encompass bradycardia, tachycardia, heart failure, among others, catering to end users such as hospitals, specialty clinics, and more.

The implantable cardiac devices market research report is one of a series of new reports from the business research company that provides implantable cardiac devices market statistics, including implantable cardiac devices industry global market size, regional shares, competitors with an implantable cardiac devices market share, detailed implantable cardiac devices market segments, market trends and opportunities, and any further data you may need to thrive in the implantable cardiac devices industry. This implantable cardiac devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The implantable cardiac devices market size has grown strongly in recent years. It will grow from $12.34 billion in 2024 to $13.46 billion in 2025 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to advances in medical technology, increasing prevalence of cardiovascular diseases, growing aging population, improvements in device reliability and longevity, rising awareness, and early diagnosis of heart conditions.

The implantable cardiac devices market size is expected to see strong growth in the next few years. It will grow to $18.81 billion in 2029 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to technological advancements in device functionality, increasing demand for minimally invasive procedures, growing geriatric population, rising healthcare expenditures, and expansion of healthcare infrastructure in emerging markets. Major trends in the forecast period include integration of digital health and remote monitoring, development of next-generation devices with enhanced features, growth in personalized and patient-specific cardiac solutions, emphasis on cost-effectiveness and value-based healthcare, increasing focus on preventive cardiology, and early intervention.

The increasing prevalence of heart diseases is expected to drive the growth of the implantable cardiac devices market. This rise can be linked to several risk factors, including unhealthy diets, sedentary lifestyles, obesity, and chronic conditions such as diabetes and hypertension. Furthermore, aging populations and elevated stress levels contribute to the higher incidence of cardiovascular issues. Implantable cardiac devices are essential for managing and treating conditions such as heart failure, arrhythmias, and coronary artery disease. The growing need for these devices fosters innovation and investment in the development of new and improved solutions to meet the demands of an expanding patient population and enhance treatment outcomes. For example, in May 2024, the Singapore Heart Foundation (SHF) reported that ischemic heart disease led to 5,302 deaths, a slight increase from 5,290 deaths in 2022. Consequently, the rising incidence of heart disease is propelling the growth of the implantable cardiac devices market.

Key companies in the implantable cardiac devices market are concentrating on improving compatibility with diagnostic tools, such as AutoMRI, to extend device lifespan and enhance patient safety. The AutoMRI feature in implantable cardiac defibrillators automatically adjusts device settings to ensure safe operation during MRI scans, thereby facilitating access to advanced imaging technology while enhancing patient care. For instance, in October 2023, MicroPort CRM, a France-based medical device company, launched the ULYS implantable cardioverter defibrillator (ICD) and INVICTA defibrillation leads in Japan. These products incorporate advanced technology with low current consumption for extended device lifespan and MRI compatibility. The ULYS ICD features the PARAD+ arrhythmia discrimination algorithm and AutoMRI functionality, while the INVICTA lead provides precise pacing and defibrillation therapy, boasting a 100% implantation success rate and a 97.4% complication-free rate in clinical trials.

In February 2022, Genesis MedTech Group, a Singapore-based medical device manufacturer, acquired JC Medical (JCM) for an undisclosed amount. This acquisition aims to enhance Genesis's product portfolio by adding the J-Valve, a minimally invasive transcatheter aortic valve replacement (TAVR) device designed for patients with aortic regurgitation and stenosis. JC Medical (JCM) is a U.S.-based manufacturer specializing in structural heart devices and cardiac implants.

Major companies operating in the implantable cardiac devices market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Koninklijke Philips N.V., Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Edwards Lifesciences Corporation, Biotronik SE & Co. KG, Zoll Medical Corporation, Nihon Kohden Corporation, LivaNova plc, Lepu Medical Technology, MicroPort Scientific Corporation, AtriCure Inc., LifeTech Scientific Corporation, Berlin Heart GmbH, EBR Systems Inc., Defibtech LLC, CVRx Inc., Progetti Srl, Endotronix Inc., Jarvik Heart Inc., Xeltis AG, Carmat SA, Windmill Cardiovascular Systems Inc

North America was the largest region in the implantable cardiac devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the implantable cardiac devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the implantable cardiac devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The implantable cardiac devices market consists of sales of products including cardiac resynchronization therapy (CRT) devices, ventricular assist devices (VADs), and implantable heart monitors. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Implantable Cardiac Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on implantable cardiac devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for implantable cardiac devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The implantable cardiac devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Pacemaker; Implantable Cardioverter Defibrillator (ICD); Biventricular Implantable Cardioverter Defibrillator (BI-V ICD)
  • 2) By Application: Bradycardia; Tachycardia; Heart Failure; Other Applications
  • 3) By End User: Hospitals; Specialty Clinics; Other End Users
  • Subsegments:
  • 1) By Pacemaker: Single-Chamber Pacemakers; Dual-Chamber Pacemakers; Rate-Responsive Pacemakers
  • 2) By Implantable Cardioverter Defibrillator (ICD): Transvenous ICDs; Subcutaneous ICDs; Wearable Cardioverter Defibrillators
  • 3) By Biventricular Implantable Cardioverter Defibrillator (BI-V ICD): Standard BI-V ICDs; Advanced BI-V ICDs with Cardiac Resynchronization Therapy (CRT)
  • Companies Mentioned: Johnson & Johnson; Abbott Laboratories; Medtronic plc; Koninklijke Philips N.V.; Stryker Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Implantable Cardiac Devices Market Characteristics

3. Implantable Cardiac Devices Market Trends And Strategies

4. Implantable Cardiac Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Implantable Cardiac Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Implantable Cardiac Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Implantable Cardiac Devices Market Growth Rate Analysis
  • 5.4. Global Implantable Cardiac Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Implantable Cardiac Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Implantable Cardiac Devices Total Addressable Market (TAM)

6. Implantable Cardiac Devices Market Segmentation

  • 6.1. Global Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pacemaker
  • Implantable Cardioverter Defibrillator (ICD)
  • Biventricular Implantable Cardioverter Defibrillator (BI-V ICD)
  • 6.2. Global Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bradycardia
  • Tachycardia
  • Heart Failure
  • Other Applications
  • 6.3. Global Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Specialty Clinics
  • Other End Users
  • 6.4. Global Implantable Cardiac Devices Market, Sub-Segmentation Of Pacemaker: Single-Chamber Pacemakers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Short-Chain Imidazoline Oligomers
  • Long-Chain Imidazoline Oligomers
  • Liquid Fertilizer Solutions
  • 6.5. Global Implantable Cardiac Devices Market, Sub-Segmentation Of Implantable Cardioverter Defibrillator (ICD), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Transvenous ICDs
  • Subcutaneous ICDs
  • Wearable Cardioverter Defibrillators
  • 6.6. Global Implantable Cardiac Devices Market, Sub-Segmentation Of Biventricular Implantable Cardioverter Defibrillator (BI-V ICD), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Standard BI-V ICDs
  • Advanced BI-V ICDs with Cardiac Resynchronization Therapy (CRT)

7. Implantable Cardiac Devices Market Regional And Country Analysis

  • 7.1. Global Implantable Cardiac Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Implantable Cardiac Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Implantable Cardiac Devices Market

  • 8.1. Asia-Pacific Implantable Cardiac Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Implantable Cardiac Devices Market

  • 9.1. China Implantable Cardiac Devices Market Overview
  • 9.2. China Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Implantable Cardiac Devices Market

  • 10.1. India Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Implantable Cardiac Devices Market

  • 11.1. Japan Implantable Cardiac Devices Market Overview
  • 11.2. Japan Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Implantable Cardiac Devices Market

  • 12.1. Australia Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Implantable Cardiac Devices Market

  • 13.1. Indonesia Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Implantable Cardiac Devices Market

  • 14.1. South Korea Implantable Cardiac Devices Market Overview
  • 14.2. South Korea Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Implantable Cardiac Devices Market

  • 15.1. Western Europe Implantable Cardiac Devices Market Overview
  • 15.2. Western Europe Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Implantable Cardiac Devices Market

  • 16.1. UK Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Implantable Cardiac Devices Market

  • 17.1. Germany Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Implantable Cardiac Devices Market

  • 18.1. France Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Implantable Cardiac Devices Market

  • 19.1. Italy Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Implantable Cardiac Devices Market

  • 20.1. Spain Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Implantable Cardiac Devices Market

  • 21.1. Eastern Europe Implantable Cardiac Devices Market Overview
  • 21.2. Eastern Europe Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Implantable Cardiac Devices Market

  • 22.1. Russia Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Implantable Cardiac Devices Market

  • 23.1. North America Implantable Cardiac Devices Market Overview
  • 23.2. North America Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Implantable Cardiac Devices Market

  • 24.1. USA Implantable Cardiac Devices Market Overview
  • 24.2. USA Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Implantable Cardiac Devices Market

  • 25.1. Canada Implantable Cardiac Devices Market Overview
  • 25.2. Canada Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Implantable Cardiac Devices Market

  • 26.1. South America Implantable Cardiac Devices Market Overview
  • 26.2. South America Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Implantable Cardiac Devices Market

  • 27.1. Brazil Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Implantable Cardiac Devices Market

  • 28.1. Middle East Implantable Cardiac Devices Market Overview
  • 28.2. Middle East Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Implantable Cardiac Devices Market

  • 29.1. Africa Implantable Cardiac Devices Market Overview
  • 29.2. Africa Implantable Cardiac Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Implantable Cardiac Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Implantable Cardiac Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Implantable Cardiac Devices Market Competitive Landscape And Company Profiles

  • 30.1. Implantable Cardiac Devices Market Competitive Landscape
  • 30.2. Implantable Cardiac Devices Market Company Profiles
    • 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Implantable Cardiac Devices Market Other Major And Innovative Companies

  • 31.1. Boston Scientific Corporation
  • 31.2. B. Braun Melsungen AG
  • 31.3. Edwards Lifesciences Corporation
  • 31.4. Biotronik SE & Co. KG
  • 31.5. Zoll Medical Corporation
  • 31.6. Nihon Kohden Corporation
  • 31.7. LivaNova plc
  • 31.8. Lepu Medical Technology
  • 31.9. MicroPort Scientific Corporation
  • 31.10. AtriCure Inc.
  • 31.11. LifeTech Scientific Corporation
  • 31.12. Berlin Heart GmbH
  • 31.13. EBR Systems Inc.
  • 31.14. Defibtech LLC
  • 31.15. CVRx Inc.

32. Global Implantable Cardiac Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Implantable Cardiac Devices Market

34. Recent Developments In The Implantable Cardiac Devices Market

35. Implantable Cardiac Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Implantable Cardiac Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Implantable Cardiac Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Implantable Cardiac Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer